Women | Men | |||||
---|---|---|---|---|---|---|
Baseline characteristics | Stroke (n=145) | No stroke (n=1286) | p Value | Stroke (n=180) | No stroke (n=1233) | p Value |
Age (years) | 66.7 (6.3) | 59.1 (10.6) | <0.0001 | 63.6 (7.1) | 58.0 (10.6) | <0.0001 |
Systolic blood pressure (mm Hg) | 157.1 (26.9) | 142.0 (23.0) | <0.0001 | 153.0 (22.4) | 142.9 (19.3) | <0.0001 |
Diastolic blood pressure (mm Hg) | 86.6 (15.2) | 80.7 (12.3) | <0.0001 | 88.7 (13.1) | 84.1 (11.4) | <0.0001 |
Body mass index (kg/m2) | 27.2 (4.7) | 25.8 (4.4) | 0.0003 | 26.5 (3.4) | 26.1 (3.3) | 0.1054 |
Total cholesterol (mmol/L) | 7.20 (1.10) | 6.82 (1.33) | 0.0010 | 6.62 (1.18) | 6.52 (1.21) | 0.2924 |
HDL cholesterol (mmol/L) | 1.61 (0.41) | 1.69 (0.42) | 0.0367 | 1.37 (0.40) | 1.41 (0.39) | 0.3038 |
Total/HDL cholesterol ratio | 4.72 (1.43) | 4.28 (1.40) | 0.0003 | 5.17 (1.73) | 4.96 (1.58) | 0.0893 |
Smoking, % (n) | 0.736 | 0.995 | ||||
No smoking | 46.2 (67) | 45.7 (587) | 20.0 (36) | 20.0 (247) | ||
Previous smoking | 22.1 (32) | 24.8 (319) | 45.6 (82) | 45.2 (557) | ||
Current smoking | 31.7 (46) | 29.6 (380) | 34.4 (62) | 34.8 (429) | ||
Hypertension, % (n) | 73.8 (107) | 52.5 (675) | <0.0001 | 77.8 (140) | 56.5 (696) | <0.0001 |
Current antihypertensive treatment, % (n) | 20.8 (30) | 11.5 (148) | <0.0001 | 19.1 (34) | 10.5 (129) | <0.0001 |
Coronary heart disease, % (n) | 5.6 (8) | 2.6 (33) | 0.06 | 15.7 (28) | 6.5 (80) | <0.0001 |
Heart failure, % (n) | 0 (0) | 0.4 (4) | 6.5 (9) | 1.3 (13) | <0.0001 | |
Palpitations, % (n) | 37.6 (41) | 30.2 (330) | 0.110 | 18.5 (29) | 18.7 (213) | 0.953 |
Diabetes, % (n) | 6.0 (8) | 1.9 (24) | 0.011 | 6.2 (11) | 2.1 (26) | 0.002 |
HbA1c (%) | 5.6 (1.0) | 5.4 (0.7) | 0.0060 | 5.6 (0.9) | 5.4 (0.6) | <0.0001 |
GFR <60, % (n) | 2.8 (4) | 1.5 (19) | 0.280 | 3.4 (6) | 0.9 (11) | 0.014 |
Mean (SD) or percentage (number of participants). The Tromsø Study 1994–1995. GFR, glomerular filtration rate; HDL, high-density lipoprotein.